NMS Labs launches another unique test suitable for the evaluation of toxicity vs. efficacy, the potential for physicians to establish therapeutic drug monitoring (TDM) of individual patients, and the assessment of drug diversion of a new pain management drug therapy.
Read MoreTrovaGene Inc–formerly Xenomics Inc– developer of transrenal molecular diagnostics, announced that LabCorp and InVivoScribe Technologies have notified the company that they have begun laboratory testing services for the detection of NPM1 mutations for the diagnosis of acute myelogenous leukemia (AML).
Read More
Testing is on the rise as deficiency is associated with cancer, stroke, osteoporosis, and other disorders.
Read MoreDIATHERIX adds a gastrointestinal (GI) panel to its lineup of sensitive, rapid response diagnostic tests. In a single result, the DIATHERIX GI panel can detect and differentiate nine types of GI infections so physicians can quickly identify patients who have severe, life-threatening infections.
Read MoreA novel diagnostic test to rapidly detect neutrophil gelatinase-associated lipocalin (NGAL), an early biomarker that identifies patients at risk for acute kidney injury (AKI), has been accepted for review by the FDA.
Read More